Chemotherapy in pancreatic carcinoma: 5 fluorouracil (5FU) and 1,3 bis-(2 chloretjyl)-1-nitrosourea (BCNU).

No abstract is available for this paper.

• Publication year

  1974

• Venue

  Annals of Surgery

• Publication date

  1974-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00000658-197404000-00012PMID 4815902PMCID PMC1355995
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Disappearance of Disseminated Pancreatic Carcinoma with Combined Chemotherapy

  1973cited by this paper
• Combination therapy with 5-fluorouracil (5-FU; NSC-19893) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for disseminated gastrointestinal carcinoma.

  1972cited by this paper
• Metastatic insulinoma treated with streptozotocin.

  1971cited by this paper
• Combination chemotherapy in gastrointestinal cancer.

  1970cited by this paper
• The rising incidence of carcinoma of the pancreas. An epidemiologic appraisal.

  1970cited by this paper
• Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer.

  1969cited by this paper
• Cancer of the pancreas.

  1968cited by this paper
• Mitomycin C (NSC-26980)--clinical brochure.

  1968cited by this paper

• Preclinical Development Impact of APE 1 / Ref-1 Redox Inhibition on Pancreatic Tumor Growth

  2011cites this paper
• Impact of APE1/Ref-1 Redox Inhibition on Pancreatic Tumor Growth

  2011cites this paper
• The impact of APE/Ref-1 on hypoxia regulated genes; potential applications for cancer

  2011cites this paper
• Reduced Expression of DNA Repair and Redox Signaling Protein APE1/Ref-1 Impairs Human Pancreatic Cancer Cell Survival, Proliferation, and Cell Cycle Progression

  2010cites this paper
• WITHDRAWN: Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.

  2009cites this paper
• Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.

  2009cites this paper
• Evaluation of MUC4 glycoprotein as a potential target for immunoliposomes in the treatment of pancreatic adenocarcinoma

  2008cites this paper
• Randomised Trial Comparing Three Different Schedules of Infusional 5FU and Raltitrexed Alone as First-Line Therapy in Metastatic Colorectal Cancer

  2006cites this paper
• Chimiothérapie des cancers du pancréas

  2006cites this paper
• Pancreatic cancer: Management

  2004cites this paper
• Fatigue in cancer patients receiving chemotherapy: an analysis of published studies.

  2004cites this paper
• Pancreatic cancer. Management.

  2004cites this paper
• Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-fluorouracil and infusional 5-fluorouracil alone in advanced pancreatic carcinoma patients.

  2004cites this paper
• Response to the letter “Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU and infusional 5-FU alone in advanced pancreatic carcinoma patients”, by C. Allior (Ann. Oncol 2004; 15: 1576–1577)

  2004cites this paper
• [Chemotherapy of cancer of the exocrine pancreas].

  1990cites this paper
• Activity of 5-Fluorouracil, Mitomycin C, and Methyl CCNU in Inoperable Adenocarcinoma of Pancreas

  1989cites this paper
• Cancer Chemotherapy by Infusion

  1987cites this paper
• Gastric, Pancreas, and Biliary Tract Cancer

  1987cites this paper
• Chemotherapie des inoperablen Pankreaskarzinoms

  1986cites this paper
• Treatment with secretin and a cholecystokinin-like peptide in patients with pancreatic cancer. A pilot study.

  1984cites this paper
• The systemic chemotherapy of hepatic metastases.

  1983cites this paper
• Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study.

  1982cites this paper
• Phase II trial of 5‐fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM‐S) in pancreatic carcinoma

  1982cites this paper
• Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.

  1982cites this paper
• Tissue diagnosis for carcinoma of the pancreas and periampullary structures

  1982cites this paper
• A controlled trial of combination chemotherapy with 5-FU and BCNU in pancreatic cancer.

  1981cites this paper
• Randomized study of 5‐FU and ccnu in pancreatic cancer: Report of the veterans administration surgical adjuvant cancer chemotherapy study group

  1981cites this paper
• Decisions in pancreatic carcinoma.

  1980cites this paper
• Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.

  1980cites this paper
• 5‐fluorouracil, methyl‐CCNU, and radiotherapy with or without testolactone for localized adenocarcinoma of the exocrine pancreas. A southwest oncology group study

  1980cites this paper
• EVALUATION OF PALLIATIVE OPERATIONS FOR IRRESECTABLE CARCINOMA OF THE HEAD OF THE PANCREAS

  1979cites this paper
• Phase II trial of streptozotocin, mitomycin‐C and 5‐fluorouracil (SMF) in the treatment of advanced pancreatic cancer

  1978cites this paper
• [Chemotherapy for digestive carcinomas. General principles (author's transl)].

  1978cites this paper
• Combination chemotherapy against B 16 melanoma: bleomycin/vinblastine, bleomycin/cis‐diamminedichloroplatinum, 5‐fluorouracil/BCNU and 5‐fluorouracil/methyl‐CCNU

  1978cites this paper
• Cancer of the pancreas.

  1977cites this paper
• Biology, diagnosis, and chemotherapeutic management of pancreatic malignancy.

  1977cites this paper
• Current diagnosis and management of pancreatic carcinoma.

  1976cites this paper
• The integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocarcinoma.

  1975cites this paper
• Treatment of carcinoma of the pancreas with radon seed implantation and intra-arterial infusion of 5-FUDR.

  1975cites this paper
• Periampullary carcinoma.

  1975cites this paper